Skip to content

Clinical trials

Phase 1/2 Dry Eye Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dry Eye Syndromes Phase: Phase 1/2 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20132
20141
20162
20171
20181
20193
20202
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sandeep Jain, MD2
University of Illinois at Chicago2
AbbVie1
Allysta Pharmaceutical1
Cambium Bio Limited1
IVIEW Therapeutics Inc.1
Invirsa, Inc.1
Ocular Therapeutix, Inc.1
Pfizer1
R-Tech Ueno, Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dry Eye Syndromes17
Keratoconjunctivitis Sicca2
Graft vs Host Disease1
Meibomian Gland Dysfunction1
Sjogren's Syndrome1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.